AU Patent

AU2002353718B2 — Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

Assigned to Swedish Orphan Biovitrum AB · Expires 2007-05-10 · 19y expired

What this patent protects

The present invention relates to compounds with the formula (I), and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-b-hydroxysteroid dehydrogenase …

USPTO Abstract

The present invention relates to compounds with the formula (I), and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-b-hydroxysteroid dehydrogenase type 1 enzyme.

Drugs covered by this patent

Patent Metadata

Patent number
AU2002353718B2
Jurisdiction
AU
Classification
—
Expires
2007-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Swedish Orphan Biovitrum AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.